Skip to content

RedSail Technologies announces integration between Axys and Parata PASS

SPARTANBURG, S.C. – RedSail Technologies, developer of Axys, announced the launch of its integration with Parata PASS, the leading medication adherence packaging solution.

Table of Contents

SPARTANBURG, S.C. – RedSail Technologies, developer of Axys, announced the launch of its integration with Parata PASS, the leading medication adherence packaging solution. This integration marks a significant milestone in healthcare management, empowering pharmacies to enhance medication management, improve medication adherence, and streamline workflow.

By incorporating Axys and Parata PASS, pharmacies gain an advantage by offering patients the benefits of pouch packaging. This seamless integration can simplify medication management for both patients and staff, helping lead to better patient health outcomes.

The Parata PASS suite provides pharmacies with a comprehensive solution that can optimize workflow, increase prescription fill rates, and promote better patient health. From essential packagers to centralized filling hubs with multiple packagers and pouch inspectors, every product in the PASS™ suite is designed to enhance efficiency, help reduce errors, and manage inventory effectively.

The integration of Axys and Parata PASS is a part of RedSail Technologies’ commitment to providing innovative solutions that transform healthcare management. By bringing together these powerful platforms, RedSail Technologies equips pharmacies with the tools they need to thrive in an ever-evolving healthcare landscape.

“Through partnerships with innovative organizations like RedSail, we’re able to expand the impact of our solutions to deliver efficiencies across the healthcare continuum,” said John Clifford, the Senior Director of Research and Development at Parata, a BD company. “Continual innovation of our solutions, such as PASS™, keeps us at the forefront of pharmacy automation technology and empowers us to reach an ever-increasing number of pharmacists.”

Comments

Latest